Monoclonal IgM Antibodies Targeting Candida Albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2020.00076
Full Text
Open PDFAbstract
Available in full text
Date
February 18, 2020
Authors
Publisher
Frontiers Media SA